Free shipping on all orders over $ 500

 About 1 result found for searched term "851627-62-8" (0.215 seconds)

Cat.No.  Name Target
M25447 PR-104 DNA/RNA Synthesis
PR-104 is a novel hypoxia-activated DNA cross-linking agent with marked activity against human tumor xenografts, both as monotherapy and combined with radiotherapy and chemotherapy.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.